Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study
- DOI
- 10.1507/endocrj.ej25-0116
- Published
- 2026
- Container
- Endocrine Journal
- Publisher
- Japan Endocrine Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1507/endocrj.ej25-0116,
title = {Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study},
author = {Koji Muroya and Masanobu Kawai and Hiroyuki Yamagishi and Takaaki Endo and Alberto Pietropoli and Jean-Marc Ferran and Reiko Horikawa},
year = {2026},
journal = {Endocrine Journal},
doi = {10.1507/endocrj.ej25-0116},
url = {https://doi.org/10.1507/endocrj.ej25-0116}
}RIS
TY - JOUR TI - Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study AU - Koji Muroya AU - Masanobu Kawai AU - Hiroyuki Yamagishi AU - Takaaki Endo AU - Alberto Pietropoli AU - Jean-Marc Ferran AU - Reiko Horikawa PY - 2026 JO - Endocrine Journal DO - 10.1507/endocrj.ej25-0116 UR - https://doi.org/10.1507/endocrj.ej25-0116 ER -
APA
Muroya, K., Kawai, M., Yamagishi, H., Endo, T., Pietropoli, A., Ferran, J., & Horikawa, R. (2026). Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study. Endocrine Journal. https://doi.org/10.1507/endocrj.ej25-0116
Source records
- crossref · retrieved 2026-11-09T10:46:05.250Z